Searched for
CHRISTOPHER VIEHBACHER
Indian pharmaceutical industry set for major transformation: Dilip ShanghviAt an annual meeting of the USA-India Chamber of Commerce in Boston, Shanghvi told a gathering of leading multinational drug makers about t...- Biogen appoints ex-Sinofi boss Christopher Viehbacher as its next CEO. Here are the detailsAfter a month gap in choosing the new CEO after Michel Vounatsos, Biogen has finally named Christopher Viehbacher as its new CEO.
- PureTech appoints Kiran Mazumdar Shaw on boardOn joining the board, Shaw will become a member of the board's Remuneration and Nomination Committees, the statement said.
- Codified rules for doctor-drug firm relations bring transparency, says Christopher ViehbacherInnovative products will not impact diabetes in India on their own. Without proper access to effective care, the epidemic will continue.
- Sanofi to join hands with Apollo Hospitals for diabetes clinics rolloutApollo Sugar will be a part of Apollo Health & Lifestyle, the arm of Apollo that is into primary and secondary healthcare.
- French pharma giant Sanofi Aventis lines up $300 million for Shantha facility in HyderabadThe company will continue to reduce its reliance on big products such as Plavix, which is the world’s second-best-selling drug with 2010 sa...
- Sanofi extends $18.5 bn bid for Genzyme againIn a statement Sanofi-aventis said its offer of $69 per Genzyme share was extended till February 15 midnight.
- Sanofi extends $18.5bn offer for Genzyme till Jan 21Sanofi-aventis has a significant presence in India. Last year, Sanofi-aventis had sought to acquire an 80pc stake in ShanthaBiotechnics for...
- Sanofi-Aventis buys Shantha for Rs 3,740 crThe deal between Sanofi its French owners Meriuex Alliance values the unlisted Indian company at Rs 3,740 crore, or about eight times its p...
Load More
